The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Thalidomide in the treatment of cancer cachexia: a randomised placebo controlled trial
Open accessAbstract
Background: Proinflammatory cytokines, especially tumour necrosis factor α (TNF-α), play a prominent role in the pathogenesis of cancer cachexia. Thalidomide, which is an inhibitor of TNF-α synthesis, may represent a novel and rational approach to the treatment of cancer cachexia. Aims: To assess the safety and efficacy of thalidomide in attenuating weight loss in patients with cachexia secondary to advanced pancreatic cancer. Methods: Fifty patients with advanced pancreatic cancer who had lost at least 10% of their body weight were randomised to receive thalidomide 200 mg daily or placebo for 24 weeks in a single centre, double blind, randomised controlled trial. The primary outcome was change in weight and nutritional status. Results: Thirty three patients (16 control, 17 thalidomide) were evaluated at four weeks, and 20 patients (eight control, 12 thalidomide) at eight weeks. At four weeks, patients who received thalidomide had gained on average 0.37 kg in weight and 1.0 cm 3 in arm muscle mass (AMA) compared with a loss of 2.21 kg (absolute difference −2.59 kg (95% confidence interval (CI) −4.3 to −0.8); p = 0.005) and 4.46 cm 3 (absolute difference −5.6 cm 3 (95% CI −8.9 to −2.2); p = 0.002) in the placebo group. At eight weeks, patients in the thalidomide group had lost 0.06 kg in weight and 0.5 cm 3 in AMA compared with a loss of 3.62 kg (absolute difference −3.57 kg (95% CI −6.8 to −0.3); p = 0.034) and 8.4 cm 3 (absolute difference −7.9 cm 3 (95% CI −14.0 to −1.8); p = 0.014) in the placebo group. Improvement in physical functioning correlated positively with weight gain ( r = 0.56, p = 0.001). Conclusion: Thalidomide was well tolerated and effective at attenuating loss of weight and lean body mass in patients with cachexia due to advanced pancreatic cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., Filiberti, A., Flechtner, H., Fleishman, S. B., Haes, J. C. J. M. D., et al. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.5.365 · Cited by 16,005
Sampaio, E. P., Sarno, E. N., Galilly, R., Cohn, Z. A., & Kaplan, G. (1991) · The Journal of experimental medicine · doi:10.1084/jem.173.3.699 · Cited by 1,192
Tisdale, M. J. (2002) · Nature Reviews Cancer · doi:10.1038/nrc927 · Cited by 982
Heymsfield, S., McManus, C., Smith, J., Stevens, V, & Nixon, D. (1982) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/36.4.680 · Cited by 824
Berlin, J. D., Catalano, P., Thomas, J. P., Kugler, J. W., Haller, D. G., & Benson, A. B. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.11.149 · Cited by 729
Evidence for the involvement of interleukin 6 in experimental cancer cachexia.
Strassmann, G., Fong, M., Kenney, J. S., & Jacob, C. O. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115767 · Cited by 658
Tumors secreting human TNF/cachectin induce cachexia in mice
Oliff, A., Defeo-Jones, D., Boyer, M., Martinez, D., Kiefer, D., Vuocolo, G., Wolfe, A., & Socher, S. H. (1987) · Cell · doi:10.1016/0092-8674(87)90028-6 · Cited by 640
Fearon, K. C. H. (2003) · Gut · doi:10.1136/gut.52.10.1479 · Cited by 603
Inhibition of NF-κB Activity by Thalidomide through Suppression of IκB Kinase Activity
Keifer, J. A., Guttridge, D. C., Ashburner, B. P., & Jr.Baldwin, A. S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100938200 · Cited by 478
Barber, M. D., Ross, J. A., Voss, A. C., Tisdale, M. J., & Fearon, K. C. H. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690654 · Cited by 459
NF-κB mediates the protein loss induced by TNF-α in differentiated skeletal muscle myotubes
Li, Y.-P., & Reid, M. B. (2000) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.2000.279.4.r1165 · Cited by 441
Colucci, G., Giuliani, F., Gebbia, V., Biglietto, M., Rabitti, P., Uomo, G., Cigolari, S., Testa, A., Maiello, E., & Lopez, M. (2002) · PubMed · Cited by 384
Cancer anorexia-cachexia syndrome: are neuropeptides the key?
Inui, A. (1999) · PubMed · Cited by 342
May, P. E., Barber, A., D’Olimpio, J. T., Hourihane, A., & Abumrad, N. N. (2002) · The American Journal of Surgery · doi:10.1016/s0002-9610(02)00823-1 · Cited by 318
Jatoi, A., Rowland, K., Loprinzi, C. L., Sloan, J. A., Dakhil, S. R., MacDonald, N., Gagnon, B., Novotny, P. J., Mailliard, J. A., Bushey, T. I. L., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.06.024 · Cited by 296
Costelli, P., Carbó, N., Tessitore, L., Bagby, G. J., Lopez-Soriano, F. J., Argilés, J. M., & Baccino, F. M. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116897 · Cited by 289
Bruera, E., Strasser, F., Palmer, J. L., Willey, J., Calder, K., Amyotte, G., & Baracos, V. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.01.101 · Cited by 287
Fitzsimmons, D., Johnson, C. D., George, S., Payne, S., Sandberg, A. A., Bassi, C., Beger, H. G., Birk, D., Büchler, M. W., Dervenis, C., et al. (1999) · European Journal of Cancer · doi:10.1016/s0959-8049(99)00047-7 · Cited by 282
Changes in nutritional status associated with unresectable pancreatic cancer
Wigmore, S., Plester, C., Richardson, R., & Fearon, K. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.17 · Cited by 247
Tisdale, M. J. (2001) · Nutrition · doi:10.1016/s0899-9007(01)00506-8 · Cited by 224
Cancer anorexia-cachexia syndrome: cytokines and neuropeptides
Ramos, E. J., Suzuki, S., Marks, D., Inui, A., Asakawa, A., & Meguid, M. M. (2004) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/01.mco.0000134363.53782.cb · Cited by 196
Goldberg, R. M., Loprinzi, C. L., Mailliard, J. A., O'Fallon, J. R., Krook, J. E., Ghosh, C., Hestorff, R. D., Chong, S. F., Reuter, N. F., & Shanahan, T. G. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.11.2856 · Cited by 184
McMillan, D. C., Wigmore, S. J., Wigmore, K. C. H., O’Gorman, P., Wright, C. E., & McArdle, C. S. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690077 · Cited by 174
Matthys, P., Heremans, H., Opdenakker, G., & Billiau, A. (1991) · European Journal of Cancer and Clinical Oncology · doi:10.1016/0277-5379(91)90483-t · Cited by 141
Whitehouse, A., & Tisdale, M. J. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601132 · Cited by 140
Characteristics of patients with pancreatic cancer expressing a novel cancer cachectic factor
Wigmore, S. J., Todorov, P., Barber, M. D., Ross, J. A., Tisdale, M. J., & Fearon, K. C. H. (2000) · British journal of surgery · doi:10.1046/j.1365-2168.2000.01317.x · Cited by 129
Thalidomide and its analogues inhibit lipopolysaccharide-mediated Iinduction of cyclooxygenase-2.
Fujita, J., MESTRE, J. R., Zeldis, J. B., Subbaramaiah, K., & Dannenberg, A. J. (2001) · PubMed · Cited by 123
Hn, L., Doherty, G. M., Fraker, D. L., Buresh, C. M., & Norton, J. A. (1991) · PubMed · Cited by 108
Barber, M. D., Ross, J. A., & Fearon, K. C. H. (1999) · Surgical Oncology · doi:10.1016/s0960-7404(99)00045-6 · Cited by 102
Khan, Z. H., Simpson, E. J., COLE, A. T., Holt, M., Macdonald, I. A., Pye, D., Austin, A., & Freeman, J. G. (2003) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2003.01457.x · Cited by 98
Thalidomide for the Treatment of AIDS-Associated Wasting
Kaplan, G., Thomas, S. D., Fierer, D. S., Mulligan, K. M., Haslett, P. A. J., Fessel, W. J., Smith, L. G., Kook, K. A., Stirling, D., & Schambelan, M. (2000) · AIDS Research and Human Retroviruses · doi:10.1089/08892220050140892 · Cited by 96
Thalidomide and its derivatives: emerging from the wilderness
Gordon, J., & Goggin, P. M. (2003) · Postgraduate Medical Journal · doi:10.1136/pmj.79.929.127 · Cited by 91
Self-citationHaslett, P. A. J., Hempstead, M., Seidman, C. E., Diakun, J., Vasquez, D., Freedman, V. H., & Kaplan, G. (1997) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1997.13.1047 · Cited by 89
Bauditz, J., Hämling, J., Ortner, M., Lochs, H. H., Raedler, A., & Schreiber, S. (1997) · Gut · doi:10.1136/gut.40.4.470 · Cited by 88
Thalidomide-associated deep vein thrombosis and pulmonary embolism
Bennett, C. L., Schumock, G. T., Desai, A. A., Kwaan, H. C., Raisch, D. W., Newlin, R. C., & Stadler, W. M. (2002) · The American Journal of Medicine · doi:10.1016/s0002-9343(02)01300-1 · Cited by 81
Cancer cachexia and its treatment with fish-oil-enriched nutritional supplementation
Barber, M. D. (2001) · Nutrition · doi:10.1016/s0899-9007(01)00631-1 · Cited by 69
Inhibition of experimental cancer cachexia by anti-cytokine and anti-cytokine-receptor therapy.
Strassmann, G., & Kambayashi, T. (1995) · PubMed · Cited by 49
Thalidomide Suppresses the Interleukin 1β‐Induced NFκB Signaling Pathway in Colon Cancer Cells
Jin, S. H., Kim, T. I., Han, D. S., Shin, S. K., & Kim, W. H. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04674.x · Cited by 34
Tumor growth, weight loss and cytokines in SCID mice
Murray, S., Schell, K. A., McCarthy, D. O., & Albertini, M. R. (1997) · Cancer Letters · doi:10.1016/s0304-3835(96)04519-3 · Cited by 27
Bruera, E. D., Strasser, F., Palmer, J. L., Willey, J. S., Calder, K., Amyotte, G., & Baracos, V. E. (2003) · Nutrition in Clinical Practice · doi:10.1177/0115426503018006524 · Cited by 21
Cited by
ESPEN guidelines on nutrition in cancer patients
Arends, J., Bachmann, P., Baracos, V., Barthelemy, N., Bertz, H., Bozzetti, F., Fearon, K., Hütterer, E., Isenring, E., Kaasa, S., et al. (2017) · Clinical Nutrition · doi:10.1016/j.clnu.2016.07.015 · Cited by 3,114
Baracos, V. E., Martin, L., Korc, M., Guttridge, D. C., & Fearon, K. C. H. (2018) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.105 · Cited by 1,738
Tisdale, M. J. (2009) · Physiological Reviews · doi:10.1152/physrev.00016.2008 · Cited by 1,192
Understanding the mechanisms and treatment options in cancer cachexia
Fearon, K., Arends, J., & Baracos, V. (2013) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2012.209 · Cited by 940
Management of Cancer Cachexia: ASCO Guideline
Roeland, E. J., Bohlke, K., Baracos, V. E., Bruera, E., del Fabbro, E., Dixon, S., Fallon, M., Herrstedt, J., Lau, H., Platek, M., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.20.00611 · Cited by 644
Metadata
- Authors
- Gordon, J. N., Trebble, T. M., Ellis, R. D., Duncan, H. D., Johns, T., & Goggin, P. M.
- Venue
- Gut
- Publisher
- BMJ
- Published
- 2005-03-07
- Volume
- 54
- Issue
- 4
- Pages
- 540-545
- ISSN
- 0017-5749 (ISSN-L)
- 1468-3288
- OpenAlex
- W1975230416
- Cited by
- 322
- References
- 40
- FWCI
- 11.86
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.